Hypofractionated regimens (≥8 Gy) often promote immunogenic cell death, STING-mediated type I interferon production, and synergy with checkpoint blockade, while very low doses (<1 Gy) may remodel the tumor vasculature and macrophage phenotype to allow immune infiltration [36]. Here, STING1 is linked to neoplasm.